Bailard »

Puma Biotechnology shares owned by Bailard

Quarter-by-quarter ownership of Puma Biotechnology (PBYI) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Puma Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Puma Biotechnology held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puma Biotechnology by Bailard

Quarter filed Position value Share count Share price at filing
2025-03-31 $73k 25k 2.96
2023-03-31 $44k 14k 3.09
2022-12-31 $226k 54k 4.23
2022-09-30 $127k 54k 2.37
2022-06-30 $152k 54k 2.84

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
Gilead Sciences (GILD)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)

View all positions for Bailard

Top funds holding Puma Biotechnology

Acorn Capital Advisors
Vanguard Group
BlackRock
Renaissance Technologies
Acadian Asset Management
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Russell Investments
Connor, Clark & Lunn Investment Management
Kennedy Capital Management
O'shaughnessy Asset Management
State Street Corporation
LSV Asset Management
Marshall Wace

View all funds holding Puma Biotechnology